Membrane-bound IL-15 co-expression powers a potent and persistent CD70-targeted TRuC T-cell therapy
{{output}}
Introduction: Although T-cell immunotherapies have been effective in the treatment of hematological malignancies, solid tumors have proven challenging due to the immunosuppressive microenvironment and lack of viable target antige... ...
